Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

Benzer Materyaller

• An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology
  Yazar:: Sani, Noraisyah Mohd, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017–2018 using the OpERA methodology
  Yazar:: Liberti, Lawrence, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Antibacterial activity of selected Malaysian honey
  Yazar:: Zainol, Mohd Izwan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for NASs initially approved in the time period 2014 to 2016
  Yazar:: Kühler, Thomas Christian, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for NASs initially approved in the time period 2014 to 2016
  Yazar:: Thomas Christian Kühler, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-11-01)